ClearPoint Neuro, Inc. (CLPT) Misses Q4 EPS by 50c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q4 EPS of ($0.68), $0.50 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $20.55 million versus the consensus estimate of $5.2 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• Genco rejects Diana Shipping bid, calls offer below NAV